Home / Intelligence / Webinars / Diversity in Clinical Trials: Evaluating Current Initiatives and the Impending Impact of the FDA’s Guidance
Available On Demand
Trinity’s Diversity, Equity & Inclusion (DEI) strategy team invites life sciences executives to join a lively discussion on recent research and developments in clinical trial diversity with a focus on racial and ethnic minorities. Herman Sanchez, Chief Business Officer at Trinity Life Sciences, will host this session and moderate a panel with special guests Monique Marsh—Associate Director and Co-Head of Trinity’s Marketing Communications Insights COE, Julie Bayley—Associate Director in Trinity’s Insights practice and Ari King, Associate Consultant.
Key Topics
- What initiatives are being undertaken at the corporate level to improve trial diversity?
- How effective are these initiatives?
- What impact will the FDA’s guidance have on diversity now and in the future?
In Case You Missed It
Click here to read our white paper entitled Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA’s Latest Guidance.
Featuring
Herman Sanchez
Chief Business Officer
Monique Marsh
Associate Director &
Co-Head of Trinity Marketing Communications Insights
Julie Bayley
Associate Director
Ari E. King
Associate Consultant
Complete the form below to view the on-demand webinar.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
White Papers
Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA’s Latest Guidance
To date, life sciences’ efforts towards driving equitable healthcare have centered around access to care, early identification and prevention. Meanwhile, less attention has been given to the impact of the racial and ethnic homogeneity in trial populations. Clinical trial diversity continues to be one of the greatest challenges pharmaceutical and biotech companies face in ensuring […]
Read More
Podcasts
Measures the Life Sciences Industry Can Take to Facilitate Diversity in Clinical Trials
The importance of ensuring diversity in clinical trials is undisputed, but barriers across the healthcare ecosystem still exist; what can healthcare regulators, policy makers, and manufacturers do to overcome challenges when recruiting clinical trial participants? Host, Matthew Rube, a Senior Consultant at Trinity Life Sciences, joins two of the subject-matter experts that authored Trinity Life […]
Listen Now
White Papers
Diversity in Clinical Trials Participation: A Life Sciences Perspective
Providing optimal care to all patients is an imperative that unites the various, interconnected parts of the medical field, from primary care to the pharmaceutical industry to the work of large academic medical centers. Over the past 30 years, there have been exceptional advances in care, treatment, diagnostics, and early identification of disease. Unfortunately, even […]
Read More